- Home
- SYTA vs TCRT Comparison
SYTA vs TCRT Comparison
Compare SYTA & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- TCRT
- Stock Information
- Founded
- SYTA N/A
- TCRT 1998
- Country
- SYTA Canada
- TCRT United States
- Employees
- SYTA N/A
- TCRT N/A
- Industry
- SYTA Telecommunications Equipment
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- TCRT Health Care
- Exchange
- SYTA Nasdaq
- TCRT Nasdaq
- Market Cap
- SYTA 2.8M
- TCRT 3.2M
- IPO Year
- SYTA 2020
- TCRT N/A
- Fundamental
- Price
- SYTA $6.82
- TCRT $1.80
- Analyst Decision
- SYTA
- TCRT
- Analyst Count
- SYTA 0
- TCRT 0
- Target Price
- SYTA N/A
- TCRT N/A
- AVG Volume (30 Days)
- SYTA 242.1K
- TCRT 25.3K
- Earning Date
- SYTA 11-14-2024
- TCRT 11-14-2024
- Dividend Yield
- SYTA N/A
- TCRT N/A
- EPS Growth
- SYTA N/A
- TCRT N/A
- EPS
- SYTA N/A
- TCRT N/A
- Revenue
- SYTA $11,988,979.00
- TCRT $7,000.00
- Revenue This Year
- SYTA $75.92
- TCRT N/A
- Revenue Next Year
- SYTA $19.72
- TCRT N/A
- P/E Ratio
- SYTA N/A
- TCRT N/A
- Revenue Growth
- SYTA 41.59
- TCRT N/A
- 52 Week Low
- SYTA $4.50
- TCRT $1.63
- 52 Week High
- SYTA $885.60
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- SYTA 46.44
- TCRT 44.52
- Support Level
- SYTA $6.25
- TCRT $1.67
- Resistance Level
- SYTA $7.59
- TCRT $1.87
- Average True Range (ATR)
- SYTA 1.11
- TCRT 0.15
- MACD
- SYTA 0.12
- TCRT -0.00
- Stochastic Oscillator
- SYTA 39.76
- TCRT 22.41
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.